BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/15/2021 10:27:28 AM | Browse: 763 | Download: 1409
Publication Name World Journal of Cardiology
Manuscript ID 59217
Country United States
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Anthracycline-induced cardiotoxicity: A case report and review of literature
Manuscript Source Unsolicited Manuscript
All Author List Esther G Chong, Eric H Lee, Reena Sail, Laura Denham, Gayathri Nagaraj and Chung-Tsen Hsueh
Funding Agency and Grant Number
Corresponding Author Chung-Tsen Hsueh, MD, PhD, Professor, Division of Medical Oncology and Hematology, Department of Medicine, Loma Linda University, 11175 Campus Street, CSP 11015, Loma Linda, CA 92350, United States. chsueh@llu.edu
Key Words Anthracycline; Cardiotoxicity; Doxorubicin; Troponin; Brain natriuretic peptide; Case report
Core Tip Anthracyclines may exert a direct toxic effect on cardiac myocytes, precipitating symptomatic heart failure. The case presented demonstrates an example of acute heart failure in a well-compensated young adult who did not at first glance warrant greater than routine cardiac surveillance during doxorubicin treatment course. Utilization of cardioprotective agents and cardiac strain markers such as troponin and brain natriuretic peptide may help to prevent and identify cardiac dysfunction in asymptomatic patients. Prevention of anthracycline-induced cardiotoxicity and cardiovascular toxicities of other anti-cancer therapy requires multidisciplinary approaches such as modification of cardiovascular risk factors, active management of comorbidities, and pharmacologic therapy in selected patients.
Publish Date 2021-01-15 09:56
Citation Chong EG, Lee EH, Sail R, Denham L, Nagaraj G, Hsueh CT. Anthracycline-induced cardiotoxicity: A case report and review of literature. World J Cardiol 2021; 13(1): 28-37
URL https://www.wjgnet.com/1949-8462/full/v13/i1/28.htm
DOI https://dx.doi.org/10.4330/wjc.v13.i1.28
Full Article (PDF) WJC-13-28.pdf
Full Article (Word) WJC-13-28.docx